[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
陈万青, 郑荣寿, 张思维, 曾红梅, 左婷婷, 贾漫漫, 夏昌发, 邹小农, 赫捷. 2012年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2016, 25(1): 1-8.
|
[3]
|
孙晓卫, 李威, 刘学超, 詹友庆, 周志伟. 胃癌同时性肝转移预后的多因素分析[J]. 中华肿瘤防治杂志, 2016, 23(21): 1446-1449.
|
[4]
|
侯松林, 谢兴江, 彭强, 周国俊, 李利发, 周何, 张广军, 周彤. 基于SEER数据库的胃癌肝转移预后因素分析与预后模型构建[J]. 中国普通外科杂志, 2020, 29(10): 1212-1223.
|
[5]
|
侯培锋, 张祥福, 黄昌明, 卢辉山, 王川, 吴心愿, 官国先, 郑知文. 影响早期胃癌预后及淋巴结转移因素分析[J]. 中国肿瘤, 2011, 20(4): 306-308.
|
[6]
|
卫勃, 刘国晓. 胃癌肝转移的机制[J]. 中华胃肠外科杂志, 2014, 17(7): 728-729.
|
[7]
|
Xiao, Y., Zhang, B. and Wu, Y. (2019) Prognostic Analysis and Liver Metastases Relevant Factors after Gastric and Hepatic Surgical Treatment in Gastric Cancer Patients with Metachronous Liver Metastases: A Population-Based Study. Irish Journal of Medical Science, 188, 415-424. https://doi.org/10.1007/s11845-018-1864-4
|
[8]
|
王兴国, 张亮刚, 杨中民. 胃癌异时性肝转移影响因素及不同治疗方式的效果和预后分析[J]. 中国现代普通外科进展, 2021, 24(2): 99-103.
|
[9]
|
饶显平, 郭东阳, 周天华, 卓巍. 胃癌肝转移的分子机制[J]. 中国细胞生物学学报, 2018, 40(1): 7-16.
|
[10]
|
Lee, P.C., Chiang, J.C., Chen, C.Y., Chien, Y.C., Chen, W.M., Huang, C.W., Weng, W.C., Chen, C.I., Lee, P.H., Chen, C.N. and Lee H. (2019) Calreticulin Regulates Vascular Endothelial Growth Factor—A MRNA Stability in Gastric Cancer Cells. PLoS ONE, 14, Article ID: e0225107. https://doi.org/10.1371/journal.pone.0225107
|
[11]
|
Mimori, K., Fukagawa, T., Kosaka, Y., Kita, Y., Ishikawa, K., Etoh, T., et al. (2008) Hematogenous Metastasis in Gastric Cancer Requires Isolated Tumor Cells and Exprssion of Vascular Endothelial Growth Factor Receptor-1. Clinical Cancer Research, 14, 2609-2616. https://doi.org/10.1158/1078-0432.CCR-07-4354
|
[12]
|
Lwin, Z.M., Guo, C., Salim, A., Yip, G.W., Chew, F.T., Nan, J., et al. (2010) Clinicopathological Significance of Calreticuli in Breast Invasive Ductal Carcinoma. Modern Pathology, 23, 1559-1566.
https://doi.org/10.1038/modpathol.2010.173
|
[13]
|
Lee, J., Lee, J., Yu, H., Choi, K. and Choi, C. (2011) Differential Dependency of Human Cancer Cells on Vascular Endothelial Growth Factor-Mediated Autocrine Growth and Survival. Cancer Letters, 309, 145-150.
https://doi.org/10.1016/j.canlet.2011.05.026
|
[14]
|
Lee, J., Ku, T., Yu, H., Chong, K., Ryu, S.W., Choi, K., et al. (2012) Blockade of VEGF-A Suppressestumor Growth Via Inhibition of Autocrine Signaling through FAK and AKT. Cancer Letters, 318, 221-225.
https://doi.org/10.1016/j.canlet.2011.12.014
|
[15]
|
Yuan, H., Chen, Z., Bai, S., Wei, H., Wang, Y., Ji, R., Guo, Q., Li, Q., Ye, Y., Wu, J., Zhou, Y. and Qiao L. (2018) Molecular Mechanisms of LncRNA SMARCC2/miR-551b-3p/TMPRSS4 Axis in Gastric Cancer. Cancer Letters, 418, 84-96. https://doi.org/10.1016/j.canlet.2018.01.032
|
[16]
|
Liu, H.-T., Ma, R.-R., Lv, B.-B., Zhang, H., Shi, D.-B., Guo, X.-Y., Zhang, G.-H. and Gao, P. (2020) LncRNA-HNF1A-AS1 Functions as a Competing Endogenous RNA to Activate PI3K/AKT Signalling Pathway by Sponging MiR-30b-3p in Gastric Cance. British Journal of Cancer, 122, 1825-1836. https://doi.org/10.1038/s41416-020-0836-4
|
[17]
|
Chen, D., Cao, G., Qiao, C., Liu, G., Zhou, H. and Liu, Q. (2018) Alpha B-Crystallin Promotes the Invasion and Metastasis of Gastric Cancer Via NF-κB-Induced Epithelial-Mesenchymal Transition. Journal of Cellular and Molecular Medicine, 22, 3215-3222. https://doi.org/10.1111/jcmm.13602
|
[18]
|
Sánchez-Tilló, E., Liu, Y., De Barrios, O., Siles, L., Fanlo, L., Cuatrecasas, M., Darling, D.S., Dean, D.C., Castells, A. and Postigo, A. (2012) EMT-Activating Transcription Factors in Cancer: Beyond EMT and Tumor Invasiveness. Cellular and Molecular Life Sciences, 69, 3429-3456. https://doi.org/10.1007/s00018-012-1122-2
|
[19]
|
Lamouille, S., Xu, J. and Derynck, R. (2014) Molecular Mechanisms of Epithelial-mesenchymal Transition. Nature Reviews Molecular Cell Biology, 15, 178-196. https://doi.org/10.1038/nrm3758
|
[20]
|
Chen, X.L., Hong, L.L., Wang, K.L., Liu, X., Wang, J.L., Lei, L., Xu, Z.Y., Cheng, X.D. and Ling, Z.Q. (2019) Deregulation of CSMD1 Targeted by MicroRNA-10b Drives Gastric Cancer Progression through the NF-κB Pathway. International Journal of Biological Sciences, 15, 2075-2086. https://doi.org/10.7150/ijbs.23802
|
[21]
|
Nishidoi, H. and Koga, S. (1987) Clinicopathological Study of Gastric Cancer with Bone Metastasis. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 14, 1717-1722.
|
[22]
|
Turkoz, F.P., Solak, M., Kilickap, S., Ulas, A., Esbah, O., Oksuzoglu, B., et al. (2014) Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival. Journal of Gastric Cancer, 14, 164-172.
https://doi.org/10.5230/jgc.2014.14.3.164
|
[23]
|
龙敏. 胃癌骨转移临床病理特征及其预后因素分析[D]: [硕士学位论文]. 南昌: 南昌大学, 2019.
|
[24]
|
Lee, J., Lim, T., Uhm, J.E., Park, K.W., Park, S.H., Lee, S.C., et al. (2007) Prognostic Model to Predict Survival Following First-Line Chemotherapy in Patients with Metastatic Gastric Adenocarcinoma. Annals of Oncology, 18, 886-891. https://doi.org/10.1093/annonc/mdl501
|
[25]
|
张高嘉, 王俊锋, 李万荣, 张云鹏, 沈志祥. 胃癌骨转移的临床特点[J]. 中国肿瘤临床, 2015, 42(9): 457-459.
|
[26]
|
Chen, C., He, W., Huang, J., Wang, B., Li, H., Cai, Q., Su, F., Bi, J., Liu, H., Zhang, B., Jiang, N., Zhong, G., Zhao, Y., Dong, W. and Lin, T. (2018) LNMAT1 Promotes Lymphatic Metastasis of Bladder Cancer Via CCL2 Dependent Macrophage Recruitment. Nature Communications, 9, Article No. 3826. https://doi.org/10.1038/s41467-018-06152-x
|
[27]
|
Yu, T., Wang, L.N., Li, W., Zuo, Q.F., Li, M.M., Zou, Q.M. and Xiao, B. (2018) Downregulation of MiR-491-5p Promotes Gastric Cancer Metastasis by Regulating SNAIL and FGFR4. Cancer Science, 109, 1393-1403.
https://doi.org/10.1111/cas.13583
|
[28]
|
Xie, M., Nie, F.Q., Sun, M., Xia, R., Liu, Y.W., Zhou, P., De, W. and Liu, X.H. (2015) Decreased Long Noncoding RNA SPRY4-IT1 Contributing to Gastric Cancer Cell Metastasis Partly via Affecting Epithelial-Mesenchymal Transition. Journal of Translational Medicine, 13, Article No. 250. https://doi.org/10.1186/s12967-015-0595-9
|
[29]
|
Leporini, C., Ammendola, M., Marech, I., Sammarco, G., Sacco, R., Gadaleta, C.D., Oakley, C., Russo, E., De Sarro, G. and Ranieri, G. (2015) Targeting Mast Cells in Gastric Cancer with Special Reference to Bone Metastases. World Journal of Gastroenterology, 21, 10493-10501. https://doi.org/10.3748/wjg.v21.i37.10493
|
[30]
|
Saito, H., Fukumoto, Y., Osaki, T., et al. (2006) Distinct Recurrence Pattern and Outcome of Adenocarcinoma of the Gastric Cardia in Comparison with Carcinoma of Other Regions of the Stomach. World Journal of Surgery, 30, 1864-1869. https://doi.org/10.1007/s00268-005-0582-z
|
[31]
|
Zhao, B., Zhang, J., Zhang, J., Luo, R., Wang, Z., Xu, H. and Huang, B. (2018) Assessment of the 8th Edition of TNM Staging System for Gastric Cancer: The Results from the SEER and a Single-Institution Database. Future Oncology, 14, 3023-3035. https://doi.org/10.2217/fon-2018-0299
|
[32]
|
Kooby, D.A., Suriawinata, A., Klimstra, D.S., Brennan, M.F. and Karpeh, M.S. (2003) Biologic Predictors of Survival in Node-Negative Gastric Cancer. Annals of Surgery, 237, 828-835.
https://doi.org/10.1097/01.SLA.0000072260.77776.39
|
[33]
|
Huang, K.H., Chen, J.H., Wu, C.W., et al. (2009) Factors Affecting Recurrence in Node-Negative Advanced Gastric Cancer. Journal of Gastroenterology and Hepatology, 24, 1522-1526.
https://doi.org/10.1111/j.1440-1746.2009.05844.x
|
[34]
|
Liu, Y., Chen, X.H., Meng, X.H., et al. (2012) Multivariate Prognostic Study on Node-Positive Gastric Cancer: Is Tumor Size a Prognostic Indicator? Hepatogastroenterology, 59, 623-626. https://doi.org/10.5754/hge11455
|
[35]
|
York, J.E., et al. (1999) Gastric Cancer and Metastasis to the Brai. Annals of Surgical Oncology, 6, 771-776.
https://doi.org/10.1007/s10434-999-0771-3
|
[36]
|
Go Pauline, H., et al. (2011) Gastrointestinal Cancer and Brain Metastasis: A Rare and Ominous Sign. Cancer, 117, 3630-3640. https://doi.org/10.1002/cncr.25940
|
[37]
|
Oh, S.Y., Lee, S.J., Lee, J., et al. (2009) Gastric Leptomeningeal Carcinomatosis: Multi-Center Retrospective Analysis of 54 Cases. World Journal of Gastroenterology, 15, 5086-5090. https://doi.org/10.3748/wjg.15.5086
|
[38]
|
Kasakura, Y., Fujii, M., Mochizuki, F., Suzuki, T. and Takahashi, T. (2000) Clinicopathological Study of Brain Metastasis in Gastric Cancer Patients. Surgery Today, 30, 485-490. https://doi.org/10.1007/s005950070112
|
[39]
|
Luo, H., Peng, L., Wang, N., Zhang, J., Zheng, X., Sun, Y., Fan, C. and Ge, H. (2018) Early Brain Metastasis of Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy Followed by Surgery: A Case Report and Literature Review. Cancer Biology & Therapy, 19, 875-878.
https://doi.org/10.1080/15384047.2018.1456600
|
[40]
|
Minn, Y.K., Lee, D.H., Hyung, W.J., Kim, J.E., Choi, J., Yang, S.H., Song, H., Lim, B.J. and Kim, S.H. (2014) MicroRNA-200 Family Members and ZEB2 Are Associated with Brain Metastasis in Gastric Adenocarcinoma. International Journal of Oncology, 45, 2403-2410. https://doi.org/10.3892/ijo.2014.2680
|
[41]
|
Sakurai, K., Muguruma, K., Murata, A., Toyokawa, T., Amano, R., Kubo, N., Tanaka, H., Yashiro, M., Maeda, K., Ohira, M. and Hirakawa, K. (2014) Early Gastric Cancer with Suspected Brain Metastasis Arising Eight Years after Curative Resection: A Case Report. BMC Research Notes, 19, Article No. 818818.
https://doi.org/10.1186/1756-0500-7-818
|
[42]
|
Gregory, P.A., Bert, A.G., Paterson, E.L., et al. (2008) The MiR-200 Family and MiR-205 Regulate Epithelial to Mesenchymal Transition by Targeting ZEB1 and SIP1. Nature Cell Biology, 10, 593-601. https://doi.org/10.1038/ncb1722
|
[43]
|
Cong, N., Du, P., Zhang, A., et al. (2013) Downregulated MicroRNA-200a Promotes EMT and Tumor Growth through the Wnt/β-Catenin Pathway by Targeting the E-Cadherin Repressors ZEB1/ZEB2 in Gastric Adenocarcinoma. Oncology Reports, 29, 1579-1587. https://doi.org/10.3892/or.2013.2267
|
[44]
|
Dai, Y.H., Tang, Y.P., Zhu, H.Y., et al. (2012) ZEB2 Promotes the Metastasis of Gastric Cancer and Modulates Epithelial Mesenchymal Transition of Gastric Cancer Cells. Digestive Diseases and Sciences, 57, 1253-1260.
https://doi.org/10.1007/s10620-012-2042-6
|
[45]
|
Jun, K.H., Lee, J.E., Kim, S.H., Jung, J.H., Choi, H.J., Kim, Y.I., Chin, H.M. and Yang, S.H. (2015) Clinicopathological Significance of N-Cadherin and VEGF in Advanced Gastric Cancer Brain Metastasis and the Effects of Metformin in Preclinical Models. Oncology Reports, 34, 2047-2053. https://doi.org/10.3892/or.2015.4191
|
[46]
|
Cavanna, L., Seghini, P., Di Nunzio, C., Orlandi, E., Michieletti, E., Stroppa, E.M., Mordenti, P., Citterio, C., Vecchia, S. and Zangrandi, A. (2018) Gastric Cancer with Brain Metastasis and the Role of Human Epidermal Growth Factor 2 Status. Oncology Letters, 15, 5787-5791. https://doi.org/10.3892/ol.2018.8054
|
[47]
|
Yang, G.L., Luo, T.H., Zhang, H.Q., Ling, C.Q. and Li, B. (2016) A Case Report of Gastric Cancer with Brain Metastasis: Rare Peripheral Nervous System Symptoms. Oncology Letters, 11, 2893-2895.
https://doi.org/10.3892/ol.2016.4288
|
[48]
|
Cinar, P., Calkins, S.M., Venook, A.P. and Kelley, R.K. (2014) Case Series of Patients with HER-2-Overexpressed Primary Metastatic Gastro-esophageal Adenocarcinoma. Anticancer Research, 34, 7357-7360.
|
[49]
|
Choy, C., Ansari, K.I., Neman, J., Hsu, S., Duenas, M.J., Li, H., Vaidehi, N. and Jandial, R. (2017) Cooperation of Neurotrophin Receptor TrkB and HER-2 in Breast Cancer Cells Facilitates Brain Metastases. Breast Cancer Research, 19, Article No. 51. https://doi.org/10.1186/s13058-017-0844-3
|
[50]
|
de Larco, J.E. and Todaro, G.J. (1978) Growth Factors from Murine Sarcoma Virus-Transformed Cells. Proceedings of the National Academy of Sciences of the United States of America, 75, 4001-4005.
https://doi.org/10.1073/pnas.75.8.4001
|
[51]
|
Logullo, A.F., Nonogaki, S., Miguel, R.E., Kowalski, L.P., Nishimoto, I.N., Pasini, F.S., Federico, M.H., Brentani, R.R. and Brentani, M.M. (2003) Transforming Growth Factor Beta1 (TGFbeta1) Expression in Head and Neck Squamous Cell Carcinoma Patients as Related to Prognosis. Journal of Oral Pathology & Medicine, 32, 139-145.
https://doi.org/10.1034/j.1600-0714.2003.00012.x
|
[52]
|
Han, S.U., Kim, H.T., Seong, D.H., Kim, Y.S., Park, Y.S., Bang, Y.J., Yang, H.K. and Kim, S.J. (2004) Loss of the Smad3 Expression Increases Susceptibility to Tumorigenicity in Human Gastric Cancer. Oncogene, 23, 1333-1341.
https://doi.org/10.1038/sj.onc.1207259
|
[53]
|
郑涛, 杨甲梅. 转化生长因子β信号通路在肝癌患者中的作用机制[J]. 中华肝胆外科杂志, 2016, 22(6): 425-428.
https://doi.org/10.3760/cma.j.issn.1007-8118.2016.06.019
|
[54]
|
王肖泽, 王继见. 胃癌转移机制研究新进展[J]. 重庆医学, 2010, 39(4): 479-481.
|
[55]
|
陈德兴, 张洪伟. 胃癌肝转移治疗现状[J]. 中国实用外科杂志, 2019, 39(4): 382-384+390.
|